PRESS RELEASE published on 01/30/2025 at 18:00, 1 year ago THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:20, 1 year ago Theranexus Unveils 2025 Financial Calendar Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE published on 01/23/2025 at 18:15, 1 year ago THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025 Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:05, 1 year ago Theranexus Announces its Financial Agenda for 2025 Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF published on 01/16/2025 at 18:05, 1 year ago Theranexus: Monthly update of voting rights and shares Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF published on 01/09/2025 at 18:05, 1 year ago Theranexus Publishes its Letter to Shareholders Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE published on 01/09/2025 at 18:00, 1 year ago THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF published on 12/17/2024 at 18:20, 1 year 1 month ago Theranexus optimizes its cash flow and extends its financial horizon Treasury Funding License Agreement Theranexus Batten Disease
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 1 month ago THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners Cash Position Cash Flow Financial Debt Theranexus Banking Partners
BRIEF published on 12/17/2024 at 18:05, 1 year 1 month ago License agreement between Theranexus and Exeltis for TX01 Rare Diseases License Agreement Theranexus Exeltis TX01
Published on 02/02/2026 at 00:05, 2 hours 16 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 1 day 23 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/01/2026 at 20:25, 5 hours 56 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 10 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 13 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 23 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days 4 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 17:45, 2 days 8 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 3 days 8 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 8 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 3 days 8 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
